Related Experiment Video

Updated: May 29, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K

Advancements in immunotherapy for hepatocellular carcinoma

Sara Ascari1, Rusi Chen1, Caterina Vivaldi2

  • 1Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Expert Review of Anticancer Therapy
|February 6, 2025
PubMed
Abstract

Insights

Immune checkpoint inhibitors have transformed hepatocellular carcinoma (HCC) treatment. Future strategies focus on overcoming resistance and developing personalized neoantigen vaccines for improved outcomes.

Area of Science:

  • Oncology
  • Immunotherapy
  • Hepatocellular Carcinoma Research

Background:

  • Immune checkpoint inhibitors have revolutionized hepatocellular carcinoma (HCC) treatment.
  • Current therapies show promise but lack direct comparisons and validated biomarkers, complicating treatment choices.
  • A significant portion of patients exhibit resistance to existing immunotherapies, necessitating new approaches.

Purpose of the Study:

  • To review current strategies for enhancing HCC immunotherapy efficacy.
  • To discuss prognostic biomarkers and methods for overcoming treatment resistance.
  • To explore novel therapeutic avenues, including neoantigen vaccines and perioperative approaches.

Main Methods:

  • Narrative review of existing literature on HCC immunotherapy.
  • Analysis of current therapeutic options and their limitations.
  • Examination of strategies to address immunotherapy resistance.

Main Results:

  • Multiple immunotherapies demonstrate superiority over traditional treatments for HCC.
  • Challenges remain in therapeutic decision-making due to lack of comparative data and biomarkers.
  • Resistance to immunotherapy is a significant clinical hurdle requiring innovative solutions.

Conclusions:

  • Future HCC systemic therapies will be driven by immunotherapy advancements.
  • Novel checkpoint inhibitors, complementary agents, and personalized neoantigen vaccines are key research areas.
  • A shift towards neoadjuvant/perioperative strategies is anticipated.
Keywords:
Hepatocellular carcinomaadjuvantbiomarkersimmunotherapyneoadjuvantvaccine

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

649
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K